CDSCO issues advisory to curb misleading promotion of prescription medications for obesity

Mar 11, 2026

The Central Drugs Standard Control Organization (CDSCO) has issued an advisory to pharmaceutical manufacturers, importers, and marketing authorization holders to ensure strict compliance with...

Govt issues guidelines on GLP-1 Drugs' use, risks, and regualtions

Apr 01, 2026

The Government of India on Thursday released details on the GLP -1 Drugs' use, risks, and regulation, according to an official press release.

Mayim Bialik reveals severe side effects after single GLP-1 dose

Jun 06, 2026

According to PEOPLE magazine, in an essay published in a U.S.-based digital news outlet, Bialik shared why she decided to try the medication and...

GLP-1 should not be used as a quick fix for weight loss and diabetes management, warns top experts

Mar 30, 2026

Top medical experts are raising urgent alarms against using GLP-1 as a lifestyle enhancer, highlighting the risk of shortages for high-risk patients.

Drug regulator inspects 49 entities over unauthorised sale of weight loss drugs

Mar 24, 2026

India's drug regulator has intensified monitoring of the supply chain of GLP-1-based weight loss drugs amid concerns over their unauthorised sale and misuse.

Lilly's orforglipron consistent with injectable GLP-1 medicines in Phase 3 trial

Apr 18, 2025

According to an official statement from Eli Lilly and Company, "Orforglipron is the first oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food...